Adverum Biotechnologies (ADVM) News Today

$0.90

-0.11 (-10.89%)

(As of 12/8/2023 ET)

Today's Range: $0.88
▼
$1.04
50-Day Range: $0.81
▼
$1.26
52-Week Range: $0.53
▼
$2.34

Volume: 408,462 shs
Average Volume: 382,507 shs
Market Capitalization: $90.93 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $3.50

Source

Source	Headline
	Adverum Biotechnologies to Present LUNA Preliminary Efficacy and Safety Data at the 47th Annual Meeting of the Macula Society finance.yahoo.com - December 7 at 7:57 PM
	Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Short Interest Update americanbankingnews.com - December 2 at 1:26 AM
	Promising Developments in Adverum Biotechnologies’ Gene Therapy Candidate, Ixo-Vec, Drive Graig Suvannavejh’s Bullish Rating markets.businessinsider.com - November 21 at 8:15 AM
	RBC Capital Reaffirms Their Hold Rating on Adverum Biotechnologies (ADVM) markets.businessinsider.com - November 11 at 1:21 PM
	Adverum Biotechnologies Reports Third Quarter 2023 Financial Results and Pipeline Highlights finance.yahoo.com - November 9 at 5:33 PM
	Why Is Eye Disease-Focused Adverum Bio Stock Trading Higher Today? msn.com - November 6 at 3:57 PM
	Adverum Biotechnologies Appoints C. David Nicholson, Ph.D. to its Board of Directors finance.yahoo.com - November 6 at 9:40 AM
	Mizuho backs Adverum Biotechnologies despite revenue decrease forecast investing.com - November 5 at 10:11 PM
	Adverum Biotechnologies Announces 3-Year Efficacy and Safety Results from the OPTIC Extension Study in Patients with Wet AMD at AAO 2023 benzinga.com - November 4 at 8:03 PM
	Adverum Biotechnologies Announces 3-Year Efficacy and Safety Results from the OPTIC Extension Study in Patients with Wet AMD at AAO 2023 finance.yahoo.com - November 4 at 8:03 PM
	Mizuho Initiates Coverage of Adverum Biotechnologies (ADVM) with Buy Recommendation msn.com - November 3 at 8:40 AM
	10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis finance.yahoo.com - October 24 at 1:09 PM
	Adverum Biotechnologies to Participate in Upcoming Investor Conferences finance.yahoo.com - September 21 at 6:08 PM
	Truist Securities Reiterates Adverum Biotechnologies (ADVM) Buy Recommendation msn.com - September 6 at 6:59 PM
	Adverum Biotechnologies to Participate in the H.C. Wainwright 25th Annual Global Investment Conference finance.yahoo.com - September 5 at 4:20 PM
	Adverum Biotechnologies (ADVM) Price Target Increased by 13.33% to 4.34 msn.com - August 31 at 8:16 AM
	Adverum Biotechnologies, Inc.: Adverum Biotechnologies Appoints Andrew Ramelmeier, Ph.D. as Chief Technology Officer finanznachrichten.de - August 22 at 7:31 AM
	Adverum Biotechnologies Appoints Andrew Ramelmeier, Ph.D. as Chief Technology Officer finance.yahoo.com - August 21 at 4:30 PM
	Adverum Biotechnologies (NASDAQ:ADVM) Now Covered by Analysts at StockNews.com marketbeat.com - August 17 at 2:43 AM
	Adverum Biotechnologies to Participate in the H.C. Wainwright 3rd Annual Ophthalmology Virtual Conference finance.yahoo.com - August 14 at 9:28 AM
	Chardan Capital Upgrades Adverum Biotechnologies (ADVM) msn.com - August 12 at 3:52 PM
	Adverum upgraded at Chardan ahead of key readouts for lead asset msn.com - August 11 at 7:50 PM
	Adverum Biotechnologies (NASDAQ:ADVM) Rating Increased to Buy at Chardan Capital marketbeat.com - August 11 at 8:00 AM
	Adverum Biotechnologies (ADVM) Price Target Increased by 7.14% to 3.83 msn.com - August 2 at 7:48 AM
	Short Volatility Alert: Adverum Biotechnologies benzinga.com - June 22 at 1:53 PM
	Adverum Biotechnologies Grants License to Ray Therapeutics Inc. for the AAV.7m8 Intravitreal Capsid finance.yahoo.com - June 12 at 4:15 PM
	GSA Capital Partners LLP Acquires 751,753 Shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM) marketbeat.com - June 7 at 7:27 AM
	Adverum Biotechnologies to Participate in the Jefferies Healthcare Conference finance.yahoo.com - June 2 at 8:47 AM
	Adverum Biotechnologies Announces New Executive Leadership Roles finance.yahoo.com - May 25 at 11:09 AM
	Adverum Biotechnologies Presents Nonclinical Data in Support of Ixo-vec's Phase 2 Clinical Development at ASGCT 2023 Annual Meeting technews.tmcnet.com - May 18 at 2:22 PM
	Adverum Biotechnologies Introduces an Intravitreal Gene Therapy Program for Geographic Atrophy and Presents Data on Its Ocular Gene Therapy Platform finance.yahoo.com - May 18 at 9:18 AM
	Adverum Biotechnologies Presents Nonclinical Data in Support of Ixo-vec’s Phase 2 Clinical Development at ASGCT 2023 Annual Meeting finance.yahoo.com - May 18 at 9:18 AM
	Adverum Biotechnologies (ADVM) Receives a Hold from RBC Capital markets.businessinsider.com - May 16 at 1:50 AM
	Adverum Biotechnologies Reports First Quarter 2023 Financial Results finance.yahoo.com - May 11 at 7:14 PM
	Adverum Biotechnologies to Participate in RBC Capital Markets Global Healthcare Conference finance.yahoo.com - May 10 at 7:31 PM
	Adverum Biotechnologies Announces Upcoming Data Presentations at ASGCT tmcnet.com - May 2 at 8:31 PM
	Adverum Biotechnologies Announces Upcoming Data Presentations at ASGCT 2023 including Data on a New Intravitreal (IVT) Geographic Atrophy Secondary to Dry AMD finance.yahoo.com - May 2 at 8:31 PM
	Adverum Biotechnologies Presents Nonclinical Data at the 2023 ARVO Annual Meeting Supporting Potential for Staggered Bilateral Administration of Ixo-vec finance.yahoo.com - April 23 at 2:40 PM
	After losing 12% in the past year, Adverum Biotechnologies, Inc. (NASDAQ:ADVM) institutional owners must be relieved by the recent gain finance.yahoo.com - April 21 at 7:55 AM
	Adverum Biotechnologies Granted Innovative Licensing and Access Pathway Designation in the United Kingdom for Ixo-vec for the Treatment of Wet AMD finance.yahoo.com - April 18 at 8:47 AM
	Adverum Biotechnologies Announces Upcoming Nonclinical Data Presentation Supporting Staggered Bilateral Administration of Ixoberogene Soroparvovec (Ixo-vec) at the 2023 ARVO Annual Meeting finance.yahoo.com - April 17 at 4:11 PM
	Adverum Biotechnologies GAAP EPS of -$0.33 beats by $0.03 msn.com - March 31 at 11:00 AM
	Adverum Biotechnologies Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Phase 2 LUNA Trial Update finance.yahoo.com - March 30 at 6:26 PM
	Adverum Biotechn (ADVM) Earnings Dates & Reports investing.com - March 21 at 10:44 PM
	Ladenburg Thalmann Initiates Coverage of Adverum Biotechnologies (ADVM) with Buy Recommendation msn.com - March 7 at 4:23 PM
	Adaptive Biotechnologies (ADPT) Shares Cross Above 200 DMA nasdaq.com - January 12 at 7:52 AM
	GI CELL Enters Agreement with Optieum Biotechnologies finance.yahoo.com - January 7 at 8:58 PM
	Adverum Biotechnologies, Inc.: Adverum Biotechnologies Reports Third Quarter 2022 Financial Results finanznachrichten.de - November 12 at 7:52 AM
	Adverum Biotechnologies Reports Third Quarter 2022 Financial Results finance.yahoo.com - November 10 at 4:19 PM
	Adverum Biotechnologies Presents Positive End of Study Results from the OPTIC Trial in Wet AMD Including Two-Year Outcomes Following a Single Intravitreal Injection of Ixo-vec (ADVM-022) finance.yahoo.com - November 4 at 7:12 PM

Get Adverum Biotechnologies News Delivered to You Automatically

ADVM Media Mentions By Week

ADVM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ADVM
News Sentiment
▼
1.42

0.52
▲
Average
Medical
News Sentiment

ADVM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ADVM Articles
This Week
▼
2

0
▲
ADVM Articles
Average Week

Get Adverum Biotechnologies News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:ADVM) was last updated on 12/9/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Adverum Biotechnologies (ADVM) News Today

ADVM Media Mentions By Week

ADVM Media Sentiment

ADVM News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info